MarketLens
Sign Up

Has Abbott Laboratories Just Redefined Its Future with Exact Sciences

8 months ago
SHARE THIS ON:

Has Abbott Laboratories Just Redefined Its Future with Exact Sciences

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 months ago

Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant

Abbott Laboratories fell 16% this year to $105.70, versus a Street consensus target of $118.42, implying ~12% upside. One analyst sees 35% gains, citing potential recovery.
Stock News•3 months ago

Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends

Abbott is expanding across diabetes care, oncology diagnostics and heart devices via new launches and acquisitions, creating multiple growth paths.
Stock News•3 months ago

Abbott Laboratories: Pick Up This Dividend King Deal Now

Abbott Laboratories shares have rallied since May, driven by strength in Medical Devices and the Exact Sciences acquisition. The company maintains an A+ S&P credit rating with stable outlook.

Breaking News

View All →

Top Headlines

View More →
Stock News•43 minutes ago

Apple posts record September quarter under new CEO as iPhone, Mac sales surge

Stock News•55 minutes ago

Alphabet Lost $500 Billion in Market Value. Should You Really Buy AI Stocks Now?

Stock News•59 minutes ago

Apple Q4: Another Solid Result

Stock News•59 minutes ago

Molly Pieroni Names GOOGL & MSFT Strong Investments in "Topsy-Turvy" Market

Stock News•1 hour ago

Apple Looks Very Smart in Modest AI Spend: Tom Forte